SOURCE-LINKED STUDY SUMMARY
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Abstract summarized · Quality not appraised
- Studied
- A retrospective matched cohort assessed whether prescribed semaglutide was associated with nonarteritic anterior ischemic optic neuropathy.
- Who / model
- Patients evaluated by neuro-ophthalmologists at one academic institution were analyzed separately for type 2 diabetes and overweight or obesity.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- Found
- Semaglutide prescriptions were associated with higher NAION risk in both clinical groups compared with non-GLP-1 medications.
- Limits
- The observational single-institution design cannot establish causality, and the authors called for further study.
Read summary source ↗ · Prepared 9/16/2026 · AI-assisted, source-based summary
Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1001/jamaophthalmol.2024.2296